A retrospective, observational study analysing efficacy of Proteasome Inhibitor-Based Regimens in Relapsed/Refractory Multiple Myeloma patients in Japan
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Bortezomib (Primary) ; Carfilzomib (Primary) ; Ixazomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association